Dave Fornell, DAIC Editor

Dave Fornell, Editor DAIC

Blog | Dave Fornell, DAIC Editor | March 26, 2015

Insights to Key Trials and Technology at ACC 2015

The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual scientific sessions involved the overwhelmingly positive late-breaking trial data for transcatheter aortic and mitral valve repair. ACC dedicated an entire day of late-breaking trial presentations to this new technology, highlighting its importance in how cardiology will be changing in the coming years, moving from invasive surgical repairs to minimally invasive percutaneous therapies. There were reservations a couple years ago among most cardiologists that transcatheter procedures would not live up to the durability and outcome standards set by surgical valve replacement, but data continue to show it is comparable, and in some cases, better. 

Watch a video explaining trends in the ACC.15 TAVR data

The poster child for transcatheter aortic valve replacement (TAVR) last year at ACC.14 was the Medtronic CoreValve, which showed a trend toward better outcomes than surgical repair. It maintained that trend in 2015, with this year’s two-year results showing CoreValve patients faired better than surgical valve replacement patients. This result stirred conjecture in a couple sessions I attended that the question in the future may change from who is best served by TAVR, to who is best served by surgery? Read about the CoreValve two-year results. 

The Edwards Lifesciences Sapien valve also performed well. The final five-year PARTNER Trial data for high-risk patients treated with the first-generation Sapien valve demonstrated equivalent outcomes to traditional open-heart surgery. There was also no structural valve deterioration requiring intervention. Additionally, data for the improved Sapien 3 device demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in high and intermediate risk patients in the PARTNER II S3 Trial. The Sapien 3 uses a skirt of material at its base to better seal the annulus to prevent paravalvular leak. 

The clinical data for a TAVR embolic protection system was also presented for the Keystone Heart TriGuard system being tested in the DEFLECT III trial. It showed a 10 percent reduction in stroke rates. 

Interventional Cardiology

The SYNTAX trials several years ago attempted to show drug-eluting stents (DES) could provide outcomes as durable as coronary artery bypass graft (CABG) surgery, but it ended with surgery edging out stents. The BEST trial presented at ACC.15 was a rematch using current generation DES, which was expected to perform better than the Taxus stent used in SYNTAX. However, results were disappointing, with surgical outcomes again trumping DES. Data show patients receiving angioplasty with newer everolimus-eluting stents had a 47 percent higher risk of one of the outcomes identified as a primary endpoint in the study — death, heart attack and subsequent procedure to clear blocked arteries — as compared to patients who received CABG.

Cardiac CT Imaging  

Two trials highlighted at ACC show a continuation of supporting data to use computed tomography angiography (CTA) as the primary diagnostic exam for patients who present with chest pain. The SCOT-HEART Trial (The Scottish Computed Tomography of the Heart Trial), which included more than 4,000 patients, showed a 38 percent reduction in the number of heart attacks in patients who received a CT scan compared with the control group getting the standard of care. The study also showed CTA changed patients’ diagnosis in about 25 percent of cases, whereas using the standard of care diagnosis were only changed about 1 percent of the time. 

The PROMISE Trial showed CTA is extraordinarily effective in accurately diagnosing patients with low to moderate chest pain. In most cases, coronary CTA is at least as effective as diagnostic methods, such as stress tests including SPECT myocardial perfusion imaging, data show. 

New Technology

There were several new cardiovascular technologies showcased on the ACC expo floor. Watch the video Editor’s Choice of the Most Innovative New Technology to see some of my choices for the most interesting new devices. 

 

 

Related Content

New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Twelve-Month Data Show Efficacy of Pulsar-18 Bare Metal Stent
News | Stents Peripheral| April 28, 2017
Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world setting, according to the...
Mercator MedSystems Announces First Enrollment in TANGO Trial for Below-the-Knee Vascular Disease
News | Peripheral Arterial Disease (PAD)| April 27, 2017
Mercator MedSystems Inc. announced the first patient enrollment into the TANGO (Temsirolimus Adventitial Delivery to...
News | Venous Therapies| April 26, 2017
A new Varicose Vein Registry has begun producing useful outcomes information, as reported in the May edition of the...
Twelve-Month Data Positive for Ranger Paclitaxel-Coated Balloon Catheter
News | Drug-Eluting Balloons| April 26, 2017
Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA Balloon Catheter at...
Body Weight Fluctuations Linked to More Deaths in People with Coronary Artery Disease
News | Cardiac Diagnostics| April 25, 2017
Repeated cycles of weight loss and gain may be linked to higher risk for stroke, heart attack and death in people with...
Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Over Niobe II System
News | Robotic Systems| April 24, 2017
A recent study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France validated the advantages of...
Alabama Medical Center First in Southeast to Offer CoreValve Evolut Pro TAVR Device
News | Heart Valve Technology| April 20, 2017
The Structural Heart Program at Princeton Baptist Medical Center, (Birmingham, Ala.) recently became the first center...
Updated AATS Guidelines Help Cardiovascular Surgeons Navigate Challenges of Managing Ischemic Mitral Regurgitation
News | Heart Valve Technology| April 20, 2017
April 20, 2017 — Mitral regurgitation can occur in up to 50 percent of patients with ischemic heart disease and even
USC Study Finds Potassium-Rich Diet Can Lower Blood Pressure
News | Hypertension| April 19, 2017
Eating potassium-rich foods like sweet potatoes, avocados, spinach, beans, bananas and even coffee could be key to...
Overlay Init